BRIEF-BridgeBio Pharma Announces Proposed Public Offering Of Common Stock

Reuters03-05

March 4 (Reuters) - BridgeBio Pharma Inc :

* BRIDGEBIO PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

* BRIDGEBIO PHARMA INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $250 MILLION OF SHARES OF ITS COMMON STOCK

* BRIDGEBIO PHARMA INC - ALSO INTENDS TO GRANT UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL $37.5 MILLION OF SHARES OF ITS COMMON STOCK

Source text for Eikon: Further company coverage:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2417193177?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-03-05 05:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2417193177","market":"us","top_or_hot":-1,"title":"BRIEF-BridgeBio Pharma Announces Proposed Public Offering Of Common Stock","media":"Reuters","content":"<html><body><p>March 4 (Reuters) - BridgeBio Pharma Inc   :</p><p>   * BRIDGEBIO PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK</p><p>   * BRIDGEBIO PHARMA INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $250 MILLION OF SHARES OF ITS COMMON STOCK</p><p>   * BRIDGEBIO PHARMA INC - ALSO INTENDS TO GRANT UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL $37.5 MILLION OF SHARES OF ITS COMMON STOCK</p><p>Source text for Eikon:    Further company coverage:   </p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-BridgeBio Pharma Announces Proposed Public Offering Of Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-BridgeBio Pharma Announces Proposed Public Offering Of Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-05 05:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>March 4 (Reuters) - BridgeBio Pharma Inc   :   * BRIDGEBIO PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK   * BRIDGEBIO PHARMA INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $250 ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BBIO","symbol_name":"BridgeBio Pharma, Inc.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2417193177","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2417193177","pubTimestamp":1709587161,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 4  - BridgeBio Pharma Inc   :   * BRIDGEBIO PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK   * BRIDGEBIO PHARMA INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $250 MILLION OF SHARES OF ITS COMMON STOCK   * BRIDGEBIO PHARMA INC - ALSO INTENDS TO GRANT UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL $37.5 MILLION OF SHARES OF ITS COMMON STOCKSource text for Eikon:    Further company coverage:","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BBIO":"BridgeBio Pharma, Inc.","BK4139":"生物科技","BK4505":"高瓴资本持仓"},"translate_title":"BridgeBio Pharma宣布公开发行普通股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BBIO":0.9},"content_text":"March 4 (Reuters) - BridgeBio Pharma Inc   :   * BRIDGEBIO PHARMA ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK   * BRIDGEBIO PHARMA INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $250 MILLION OF SHARES OF ITS COMMON STOCK   * BRIDGEBIO PHARMA INC - ALSO INTENDS TO GRANT UNDERWRITERS A 30-DAY OPTION TO PURCHASE UP TO AN ADDITIONAL $37.5 MILLION OF SHARES OF ITS COMMON STOCKSource text for Eikon:    Further company coverage:","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2417193177"}